Safety and efficacy of intrarenal arterial autologous CD34+ cell transfusion in patients with chronic kidney disease: A randomized, open‐label, controlled phase II clinical trial

BACKGROUND: This was a randomized, open‐label, controlled phase II clinical trial to investigate the safety, efficacy, and outcomes of intrarenal artery infusion of autologous peripheral‐blood‐derived CD34+ cells for patients with chronic kidney disease (CKD; ie, stage III or IV). MATERIALS AND METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chih‐Chao, Sung, Pei‐Hsun, Cheng, Ben‐Chung, Li, Yi‐Chen, Chen, Yi‐Ling, Lee, Mel S., Yip, Hon‐Kan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Human Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381811/
https://www.ncbi.nlm.nih.gov/pubmed/32297703
http://dx.doi.org/10.1002/sctm.19-0409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381811/
https://www.ncbi.nlm.nih.gov/pubmed/32297703
http://dx.doi.org/10.1002/sctm.19-0409

Ejemplares similares